Effect of peripheral vascular disease on kidney allograft outcomes: A study of U.S. renal data system

Transplantation

Volumn 95, Issue 6, 2013, Pages 810-815

  Brar, Amarpali ^a   Jindal, Rahul M ^b   Elster, Eric A ^b   Tedla, Fasika ^a   John, Devon ^a   Sumrani, Nabil ^a   Salifu, Moro O ^a  

^a Downstate Health Sciences University   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

Author keywords

African Americans; Allograft outcomes; Amputation; Kidney transplantation; Peripheral vascular disease

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; ALLOTRANSPLANTATION; FACTUAL DATABASE; GRAFT REJECTION; HOSPITAL ADMISSION; KIDNEY FAILURE; METHODOLOGY; MIDDLE AGED; REGISTER; RISK; UNITED STATES;

ADULT; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REGISTRIES; RENAL INSUFFICIENCY; RISK; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS;

MLCS; MLOWN;

EID: 84877618938     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827eef36     Document Type: Article

References (22)

1. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2838.
2. Liu T, Liang KV, Rosenbaum A, et al. Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO study. Nephrol Dial Transplant 2012; 27: 2929.
3. Eraso LH, Fukaya E, Mohler ER 3rd, et al. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol 2012. Epub ahead of print.
4. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999Y2000. Circulation 2004; 110: 738.
5. Ostchega Y, Paulose-Ram R, Dillon CF, et al. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999Y2004. J Am Geriatr Soc 2007; 55: 583.
6. Holman KH, Henke PK, Dimick JB, et al. Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg 2011; 54: 420.
7. Rowe VL, Weaver FA, Lane JS, et al. Racial and ethnic differences in patterns of treatment for acute peripheral arterial disease in the United States, 1998Y2006. J Vasc Surg 2010; 51: 21S.
8. Sung RS, Althoen M, Howell TA, et al. Peripheral vascular occlusive disease in renal transplant recipients: risk factors and impact on kidney allograft survival. Transplantation 2000; 70: 1049.
9. Snyder JJ, Kasiske BL, Maclean R. Peripheral arterial disease and renal transplantation. J Am Soc Nephrol 2006; 17: 2056.
10. Gill JS, Pereira BJ. Death in the first year after kidney transplantation: implications for patients on the transplant waiting list. Transplantation 2003; 75: 113.
11. Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myo-cardial infarction: the TIMI III registry. JAMA 1996; 275: 1104.
12. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, et al. Racial differences in the use of revascularization procedures after coronary angiography. JAMA 1993; 269: 2642.
13. Peterson ED, Shaw LK, DeLong ER, et al. Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med 1997; 336: 480.
14. Mukamel DB, Murthy AS, Weimer DL. Racial differences in access to high-quality cardiac surgeons. Am J Public Health 2000; 90: 1774.
15. Trivedi AN, Zaslavsky AM, Schneider EC, et al. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 2005; 353: 692.
16. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381.
17. Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006; 114: 1914.
18. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
19. Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. Am J Kidney Dis 2011; 57: 476.
20. Grace NL, Wong LL. Should peripheral vascular disease-or diabetes-related amputation contraindicate renal transplant? Hawaii J Med Public Health 2012; 71: 181.
21. Grisafi JL, Dadachanji C, Rahbar R, et al. The effect of immunosup-pression on lower extremity arterial bypass outcomes. Ann Vasc Surg 2011; 25: 165.
22. How good are the data? USRDS data validation special study. Am J Kidney Dis 1992; 20: 68.